BOPA Verification Survey

One of BOPA’s work streams for 2019 is to produce a standardised national verification training programme. To help us we need you to tell us about your verification training program.  Please click here to take our survey. or cut and paste link below https://www.surveymonkey.co.uk/r/M9BFVPG 

The survey will take 5 to 10 minutes.    As part of the survey we are asking (optional) for people to share a copy of their Trusts verification training programme.  These will be kept confidential and only used for the standardisation project.  If you are willing to share a copy of your hospitals verification training documentation please email to [email protected].

Thank You
Steve Williamson
BOPA Chair

 

Latest News

By BOPA Executive Committee on 25th April 2025

NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer at high risk of recurrence in adults.

BOPA have been involved with the following NICE TA: Ribociclib with an aromatase inhibitor can be used as an option for the adjuvant treatment of hormone receptor-positive, HER2-negative, early breast cancer…

Read article
By BOPA IO SAG on 23rd April 2025

Toolkit for Immunotherapy IV to SC switch

Dear all, In the coming months, an increasing number of products traditionally administered intravenously are expected to become available for subcutaneous administration. This shift offers enhanced flexibility for patients; however,…

Read article
By BOPA E&T subcommittee on 17th April 2025

The BOPA Cancer Consultant Pharmacist Credentialing Support Series is back

BOPA are holding a nine month supportive webinar series for pharmacists who are credentialing as consultant pharmacists with the RPS. Join in this relaxed forum to discuss about your portfolio…

Read article
By BOPA research subcommittee on 17th April 2025

Celebration of BOPA member’s recent publications

We are delighted to share that so many of our members have had manuscripts published recently. Here are some that we are aware of but if there are others then…

Read article